These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3990512)

  • 21. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors.
    Brown MJ; Harland D
    Br J Pharmacol; 1986 Feb; 87(2):361-70. PubMed ID: 3006858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis.
    Thorré K; Sarre S; Smolders I; Ebinger G; Michotte Y
    Brain Res; 1998 Jun; 796(1-2):107-16. PubMed ID: 9689460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers.
    Eriksson E; Modigh K; Carlsson A; Wikström H
    Eur J Pharmacol; 1983 Dec; 96(1-2):29-36. PubMed ID: 6662196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential electrophysiological effects of 3-PPP and its enantiomers on dopamine autoreceptors and postsynaptic receptors.
    Bergstrom DA; Carlson JH; Bromley SD; Jackson DM; Walters JR
    Eur J Pharmacol; 1986 May; 124(1-2):75-84. PubMed ID: 3720847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.
    Andén NE; Nilsson H; Ros E; Thornström U
    Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):51-6. PubMed ID: 6301216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
    Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ritanserin, a 5-HT2A/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons.
    Shi WX; Nathaniel P; Bunney BS
    J Pharmacol Exp Ther; 1995 Aug; 274(2):735-40. PubMed ID: 7636736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain.
    Chernoloz O; El Mansari M; Blier P
    Neuropsychopharmacology; 2009 Feb; 34(3):651-61. PubMed ID: 18688211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology.
    Grace AA; Bunney BS
    Brain Res; 1985 May; 333(2):285-98. PubMed ID: 3995296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the presence of autoreceptors on dopamine neurons in different brain regions.
    Andén NE; Grabowska-Andén M; Liljenberg B
    J Neural Transm; 1983; 57(3):129-37. PubMed ID: 6139410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological evaluation of a partial agonist of dopamine receptors.
    Piercey MF; Hoffmann WE; Vogelsang GD; Travis M
    J Pharmacol Exp Ther; 1987 Oct; 243(1):391-6. PubMed ID: 3668865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA; Christofferson CL; Corbin A; DeWald HA; Demattos S; Meltzer LT; Myers SL; Shih YH; Whetzel SZ; Wiley JN
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1147-58. PubMed ID: 1361570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
    Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
    Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra.
    Engberg G; Kling-Petersen T; Nissbrandt H
    Synapse; 1993 Nov; 15(3):229-38. PubMed ID: 8278899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereoselective inhibition of prolactin secretion by (-)-HW-165, a novel 3-PPP congener; further support for similarities between central DA autoreceptors and pituitary lactotroph DA receptors.
    Hjorth S; Eriksson E; Andersson B
    Eur J Pharmacol; 1986 Jun; 125(3):421-8. PubMed ID: 3755402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexual excitement and stretching and yawning induced by B-HT 920.
    Ferrari F
    Pharmacol Res Commun; 1985 Jun; 17(6):557-64. PubMed ID: 2862647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of K+-stimulated [3H]dopamine and [14C]acetylcholine release by the putative dopamine autoreceptor agonist, B-HT 920.
    Schmidt CJ; Lobur A; Lovenberg W
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):377-82. PubMed ID: 2434870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L; Pitts DK
    J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.